GSK-812结构式
|
常用名 | GSK-812 | 英文名 | GSK-812 |
---|---|---|---|---|
CAS号 | 630407-66-8 | 分子量 | 471.99600 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C25H26ClNO4S | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
GSK-812用途GSK-812 is a potent neuroprotectant that can induce GDNF in normal and diseased retina, shows has polypharmacology antagonizing multiple receptors, including D2 and D3 receptors, and 5-HT2A, 2C, and 5-HT6 receptors.. |
英文名 | 7-({4-[(4-Chlorobenzyl)oxy]phenyl}sulfonyl)-8-methoxy-3-methyl-2, 3,4,5-tetrahydro-1H-3-benzazepine |
---|---|
英文别名 | 更多 |
分子式 | C25H26ClNO4S |
---|---|
分子量 | 471.99600 |
精确质量 | 471.12700 |
PSA | 64.22000 |
LogP | 5.80950 |
~% GSK-812 630407-66-8 |
文献:GLAXO GROUP LIMITED Patent: WO2005/51916 A1, 2005 ; Location in patent: Page/Page column 7; 27 ; WO 2005/051916 A1 |
GSK-812上游产品 2 | |
---|---|
GSK-812下游产品 0 |
Abilitat-d8 |
Abilify-d8 |